Metraipolis › archive › dc_aae899ccd5ac
Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling — Europe PMC PMID:42796408
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42796408
- DOI
- 10.3390/medicina62091802
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:16:12.584Z
- SHA-256 of the archived text
e686738f418f2a35a46b26579a06a584ccf8292622d3262a10a520392ac24bd0- Stable URL of this page
https://metraipolis.com/documento/dc_aae899ccd5ac
How to cite
Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling — Europe PMC PMID:42796408 — Europe PMC (en), https://europepmc.org/article/MED/42796408 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aae899ccd5ac (Metraipolis archive dc_aae899ccd5ac, sha256 e686738f418f2a35a46b26579a06a584ccf8292622d3262a10a520392ac24bd0)
BibTeX
@misc{dcaae899ccd5ac,
title = {Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling — Europe PMC PMID:42796408},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42796408},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aae899ccd5ac; sha256 e686738f418f2a35a46b26579a06a584ccf8292622d3262a10a520392ac24bd0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42796408. Agents can read the archived copy with the MCP tool read_document.